Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
50–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects and their caregivers must provide informed consent prior to study entry.
Subjects must have a clinical diagnosis of probable mild-to-moderate Alzheimer's disease with a documented 6-month history of AD symptoms
Subjects must have a regular caregiver who is willing to attend visits, oversee the subject's compliance with the study and report on the subject's status.
Female subjects of child-bearing potential must agree to pregnancy testing and approved form of birth control.
You may not be if
Diagnosis of possible, probable or definite vascular dementia.
History/evidence of any other CNS disorder that could be interpreted as a cause of dementia
History of known or suspected seizures, loss of consciousness or significant head trauma
Subjects with ECG, blood pressure and laboratory values outside of protocol criteria are excluded.
Subjects with known photosensitivity
Subjects with a history of previous exposure to SB-742457, taking agents for which there is a theoretical risk of interaction with SB-742457, or taking medication for Alzheimer's disease or centrally acting agents which might impact study outcomes may not participate.
